Snowball logo
logo
AVDL

Avadel Pharmaceuticals plc

AVDL β€’ NASDAQ
$21.64$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
22.33-1.49627.96169.1248.5
COGS
5.7420.8151.4930.84615.2813.75
Gross Profit
16.59(0.815)(1.493)27.12153.8234.8
Operating Expenses & Income
Operating Income
5.815(85.55)(98.56)(137.8)(42.4)4.523
Total Operating Expenses
10.7885.5598.56165196.2230.2
R&D Expenses
20.4417.120.713.2615.239.89
Selling General & Admin Expenses
32.4168.574.52151.7181191.5
Earnings from Continuing Operations
Interest Expense
(12.99)(9.942)(12.34)(9.886)(10.83)(9.71)
Interest Income
------
Income Tax Expense
(12.11)(15.82)26.02(0.501)(0.247)(2.978)
Net Income
Net Income
7.028(77.33)(137.5)(160.3)(48.83)(0.278)
Supplemental
EBIT
7.912(83.2)(99.1)(150.9)(38.25)6.454
EBITDA
9.602(82.39)(97.6)(149.1)(35.57)10.13
In millions of USD, except % and values per 1 share